At Achelab Laboratory Services, our R&D division is leading efforts to identify and characterize bioactive compounds from East Africa’s indigenous medicinal plants to develop new therapeutics against antimicrobial resistance (AMR).
Our pilot project focuses on Commiphora myrrha (Myrrh) — a resin traditionally used for its antimicrobial, anti-inflammatory, and wound-healing properties. We are establishing a standardized extract library (aqueous, ethanolic, and essential oil fractions) and developing two prototype dosage forms — an ointment and a capsule.